Skip to main content

Settlements

AG Pax­ton: Set­tle­ment Agree­ment Against Tobac­co Com­pa­nies Must Be Enforced

Attorney General Ken Paxton applauded a ruling from the U.S District Court for the Eastern District of Texas, holding that a 1998 comprehensive settlement agreement with R.J. Reynolds Tobacco Company and other tobacco companies stands and the agreed payments to the state for smoking-related healthcare costs must be enforced.

February 26, 2020 | Press Release

AG Pax­ton Announces Set­tle­ment Agree­ment with T‑Mobile on Sprint Merger

Attorney General Ken Paxton today announced that his office reached a settlement with T-Mobile resolving the state’s antitrust claims against the proposed merger of mobile wireless telecommunications service providers Sprint and T-Mobile.

November 25, 2019 | Press Release

AG Pax­ton Announces $116.9 Mil­lion Mul­ti­state Set­tle­ment with John­son & John­son, Ethicon, Inc. for Decep­tive Mar­ket­ing of Sur­gi­cal Mesh Med­ical Devices

Attorney General Ken Paxton today announced a $116.9 million multistate settlement with Johnson & Johnson and its subsidiary Ethicon, Inc. for deceptively marketing transvaginal surgical mesh devices.

October 18, 2019 | Press Release

AG Pax­ton and 48 States Reach $45 Mil­lion Set­tle­ment with PHH Mort­gage Corporation

“This settlement sets up strict requirements for servicing standards to help ensure that PHH can no longer improperly service mortgages,” Attorney General Paxton said. “Texas is dedicated to holding accountable any person or business that harms homeowners so egregiously.”

January 03, 2018

AG Pax­ton Announces $13.5 Mil­lion Set­tle­ment with Phar­ma­ceu­ti­cal Com­pa­ny in Decep­tive Mar­ket­ing Case

“It is alarming that a pharmaceutical company deceived Texans into potentially taking dangerous doses of medications that may not treat their underlying health conditions,” Attorney General Paxton said. “This settlement makes clear that we will hold pharmaceutical companies accountable for misleading claims made in advertising. Texans should be able to trust that ads for prescription medications are medically accurate.”

December 21, 2017